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Background: There has been a theoretical debate as to which retrospective record review method is the most
valid, reliable, cost efficient and feasible for detecting adverse events. The aim of the present study was to evaluate
the feasibility and capability of two common retrospective record review methods, the “Harvard Medical Practice
Study” method and the “Global Trigger Tool” in detecting adverse events in adult orthopaedic inpatients.
Methods: We performed a three-stage structured retrospective record review process in a random sample of 350
orthopaedic admissions during 2009 at a Swedish university hospital. Two teams comprised each of a registered
nurse and two physicians were assigned, one to each method. All records were primarily reviewed by registered
nurses. Records containing a potential adverse event were forwarded to physicians for review in stage 2. Physicians
made an independent review regarding, for example, healthcare causation, preventability and severity. In the third
review stage all adverse events that were found with the two methods together were compared and all
discrepancies after review stage 2 were analysed. Events that had not been identified by one of the methods in the
first two review stages were reviewed by the respective physicians.
Results: Altogether, 160 different adverse events were identified in 105 (30.0%) of the 350 records with both methods
combined. The “Harvard Medical Practice Study” method identified 155 of the 160 (96.9%, 95% CI: 92.9-99.0)
adverse events in 104 (29.7%) records compared with 137 (85.6%, 95% CI: 79.2-90.7) adverse events in 98 (28.0%)
records using the “Global Trigger Tool”. Adverse events “causing harm without permanent disability” accounted for
most of the observed difference. The overall positive predictive value for criteria and triggers using the “Harvard
Medical Practice Study” method and the “Global Trigger Tool” was 40.3% and 30.4%, respectively.
Conclusions: More adverse events were identified using the “Harvard Medical Practice Study” method than using
the “Global Trigger Tool”. Differences in review methodology, perception of less severe adverse events and
context knowledge may explain the observed difference between two expert review teams in the detection of
adverse events.
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The “Harvard Medical Practice Study” (HMPS) [1]
provided researchers with a retrospective record review
method for identifying the incidence of adverse events
(AEs) using 18 screening criteria. The method has
undergone modifications in subsequent studies [2-6].
The ”Global Trigger Tool” (GTT) method, developed
after HMPS and popularised by the Institute for
Healthcare Improvement [7], is a method widely used
for retrospective reviews in patient safety work. The
GTT was primarily designed as a quality improvement
tool in to be used in clinical practice for estimating and
tracking AE rates over time using 54 triggers [8-14]. The
HMPS method is mostly used for research purposes and
not in local, routine data collection or for evaluating
patient safety interventions in contrast with GTT [15].
Both methods are based on a structured approach to
identify events empirically associated with healthcare-
related harm. An overview of similarities and differences
between the two methods is presented in Table 1.
There has been a theoretical debate as to which retro-
spective record review method is the most valid, reliable,
cost efficient and feasible [15]. A limitation when com-
paring different retrospective record review studies is
that the AE definition, inclusion frame, settings and the
presentation of the AE rates have varied. It is of interest
to evaluate the feasibility and capability of using different
retrospective record review methods to identify AEs at
departmental level since record review is increasingly
used in local patient safety initiatives. To the best of our
knowledge, the HMPS method and the GTT have not
previously been evaluated on the same sample.
The aim of the study was to evaluate the feasibility
and capability of the HMPS method and the GTT to
identify AEs in a specified clinical setting.
Methods
Setting and sampling
The study was performed at a university hospital in the
Stockholm metropolitan area, with a four-ward, 52-bed,
orthopaedic department, including both elective and
acutely admitted inpatients.
All orthopaedic inpatient admissions during 2009
(n=3701) were available for randomisation, irrespective
of length of stay. Based on earlier studies [2,3,22-24] we
estimated that AEs would occur in 16% of admissions
and calculated that a sample of 350 admissions would be
sufficient to estimate the prevalence of AEs with a 95%
CI of ± 3.8%.
Definitions and inclusion criteria
For both methods an AE was defined as an unintended
harm to the patient that was caused by healthcare rather
than by the patient’s underlying disease process. Incontrast to earlier HMPS method studies [1,5,6,18,25],
we did not require that the AE prolonged the hospital
stay or caused disability at the time of discharge. Both
acts of omission and acts of commission were included.
A preventable AE was defined as an error in healthcare
management due to failure in following accepted prac-
tice at the level of the individual or of the system [2,4].
The orthopaedic admission in the random sample con-
stituted the index admission. To be included in the study,
the AE had to be related to care given in the Orthopaedic
Department and, additionally, one of the following criteria
had to be met;
(i) The AE had to have been caused within 30 days
before index admission, leading to the index
admission, or to have been detected during the
index admission.
(ii) The AE had to have been caused and detected
during index admission.
(iii)The AE had to have been caused during index
admission and have been detected within 30 days of
index discharge from the Orthopaedic Department.
AEs identified using this criterion were not required
to result in a new admission; e.g., a postoperative
deep vein thrombosis treated on an outpatient basis
was included.
Index admissions due to deep arthroplasty infections
were included as AEs up to one year after surgery.
The computerised medical record system in which all
documentation was made by healthcare personnel and
departments at the hospital is referred to as the record.
Both inpatient and outpatient notes were included.
Screening criteria are referred to as criteria.Description of the teams
Two teams, one for each method, made the reviews.
Each team consisted of one registered nurse (RN) and
two physicians; all were used to working with patient
safety issues. The HMPS method team consisted of a
senior RN with wide experience of using criteria and
knowledge about the orthopaedic context including the
computerised record system. One physician was a senior
orthopaedic surgeon with experience in record review.
The other physician was junior without orthopaedic
context knowledge and review experience but expertise
in the field of patient safety.
The whole GTT team had extensive experience in
using the GTT method. The team consisted of senior
reviewers and even though they had been trained in
other specialties they were experienced in reviewing re-
cords from different medical specialities including ortho-
paedics and using other computerised record systems.
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AE, adverse event; NCC MERP, National Coordination Council for Medication Error Reporting and Prevention (NCC MERP) index [21]. Category A-D describes risk
and no harm incident. Category E-I describes harm.
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To standardise the review process a written manual, includ-
ing definitions and detailed examples for each method was
developed, discussed and approved by all reviewers before
the start of the study. During the process of familiarisation,
each team member independently reviewed 11 training
records on paper and a consensus process allowed discus-
sions of the AE assessments and related matters. Team
members not familiar with the specific computerised record
system received one hour’s training in theory. In order to
further familiarise with the new record system the nurse
reviewer of the GTT team read seven computerised train-
ing records before starting the review process. Questions
about the record system and local routines could be asked
when needed during the review process.
Review process including evaluation
A two-stage retrospective record review was performed.
In review stage 1, all records in the random sample were
reviewed by the RNs, one for each method (Figure 1).
They screened for the presence of one or more of 18
predefined criteria or 53 triggers, respectively. For every
criterion/trigger detected, a judgement was made by the
RN regarding whether the criterion/trigger reflected the
presence of a potential AE or not and the potential AE
was described in brief. The time taken to review each rec-
ord was documented. Only records with potential AEs
were forwarded to the physicians for review. Each phys-
ician in the respective teams reviewed half of the records
forwarded by the RN.
In review stage 2, the physicians performed an inde-
pendent review (Figure 1). A judgement was made re-
garding whether patient harm had occurred or not. An
assessment of healthcare causation was performed usinga 6-point scale [1,2]. A score of four or higher (i.e. more
than 50% likelihood of healthcare causation) was
regarded as being an AE. A similar 6-point scale was
used to judge the preventability of the AE. A score of
four or more meant that the AE was considered as
having been preventable [2]. The severity of the AE was
judged using standardised scales for the method being
used, since each method has its own severity scale
[1,21]. In addition, all physicians documented which
criterion/trigger was related to each AE. If a record
contained more than one AE, each was reviewed separ-
ately and the associated criterion/trigger was docu-
mented separately. The time taken to do the review of
each event was documented. The HMPS method team
made additional assessments about the nature of the
AEs according to the methodology. In addition to
reviewing every second forwarded record, a random
sample of the forwarded records was reviewed double-
blinded to assess inter-rater reliability between the
physicians´ judgements within each team. After inde-
pendent review of all potential AEs, the physicians in
each team discussed the duplicate reviewed records and
reached consensus.
We evaluated both teams´ nurse review processes.
First, in review stage 2 the physicians included any
additional AE they found that had not been identified by
the nurse reviewer in stage 1. Furthermore, every tenth
record that had been deemed as not containing a poten-
tial AE in the nurse review process was screened for AEs
by one of the physicians in each team.
In a third review stage all AEs that were found with the
two methods together were compared and all discrepan-
cies after review stage 2 were analysed by one of the RNs
(MU). Events that had only been identified by one of the
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Figure 1 Three-stage review process for detecting adverse events.
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team. The aim of the third review stage was twofold: the
first was to employ the external evaluation of both the
methods to reach the “true documented and confirmed
AE rate in the sample”, and the second aim was to com-
pare the physicians’ judgements in the full set of identified
AEs (Figure 1).
Statistical analysis
Categorical data are summarised using frequency
counts and proportions (percent). Both the number ofAEs per record and the number of records with at least
one AE are presented. The calculation of 95% confi-
dence interval for a proportion is based on exact
methods according to Clopper-Pearson. Continuous
data are presented as median and range/inter-quartile
range. The inter-rater reliability was calculated using
binary data. The Spearman rank order correlation coef-
ficient (rs) was used to investigate “learning curves”.
P<0.05 was considered statistically significant. Statis-
tical programs used to collate the results were Excel
and Statistica 9.0.
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Ethics approval was provided by the regional Ethics
Committee of Stockholm (number 2008/951-31/3).
Results
The review process
No records were excluded from review due to missing
documentation.
The study sample, representing 1848 hospital days,
comprised a majority of female patients (n=201, 57%)
and acutely admitted patients (n=250, 71%). The median
(interquartile range) age was 69 (53–81) years and length
of stay was four (2–7) days.
In total, 160 different AEs were identified in 105
(30.0%) of the 350 records with both methods combined
after the third review stage (Figure 1).
In review stage 1, 111 (HMPS method) and 132 (GTT)
of the 350 records contained a potential AE and were
forwarded to physician review (Figure 1).
After review stage 2, the HMPS method found 151
(94.4%, exact 95% CI: 89.6-97.4) AEs in 100 (28.6%) of
350 records, resulting in a mean rate of 0.43 AEs per
record (range 0–5), of which 131 (86.7%) were deemed
preventable. Using the GTT, the physicians identified 99
AEs (61.9%, exact 95% CI: 53.9-69.4) in 85 (24.3%) of the
records, on average 0.28 AEs per record (range 0–4),
and 77 (77.8%) of these AEs were deemed preventable
(Figure 1).
The nurse reviewer validation steps did not identify
any additional AEs for the HMPS method and identified
nine AEs for the GTT.
Four AEs not identified by the HMPS method and 43
not identified by the GTT were forwarded to the third
review stage. After the third review stage, 155 (96.9%,
exact 95% CI: 92.9-99.0) and 137 (85.6%, exact 95% CI:
79.2-90.7) AEs were identified in 104 (29.7%) and 98
(28.0%) of the 350 records by using the HMPS and GTT
methods, respectively. Of these AEs, 135 (87.1%)
(HMPS) and 110 (80.3%) (GTT) were deemed preventable
by the physicians.
Thirty (HMPS), and 43 (GTT) potential AEs were
reviewed in duplicate by the physicians. The physicians’
initial assessments before team discussions considering
healthcare causation were coherent within the teams in
93% and 88% of the cases for the HMPS and GTT
methods, respectively, and preventability in 100% and
95% of the cases, respectively.
The median (range) time for each record for nurse
review was three (1–35) versus eight (1–20) minutes for
the HMPS and GTT methods, respectively. A negative
correlation between nurse review time and serial sam-
ples number was demonstrated for both methods, rs for
the HMPS method was −0.36, (p<0.001), and rs for GTT
was −0.44, (p<0.001), indicating a “learning curve” forboth RNs. The median review time for both physician
reviewers using the HMPS method was six minutes
(range 2–18 and 2–31 minutes). In the GTT team, me-
dian times were four and eight minutes (range 1–15 and
2–30 minutes).
We analysed the AEs not identified after review stage
2 (n=4 (HMPS) and 43 (GTT)). For GTT there were no
differences in types and rates of unidentified AEs
irrespective of whether assessment was performed early
or late in the review process. The description, nature
and potential underlying causes to the missed AEs for
both methods after review stage 2 are presented in
Table 2.
Positive predictive value
A total of 466 (range: 1–11 per record) criteria and 737
(range: 1–13 per record) triggers were identified in 195
(HMPS) and 233 (GTT) records after the third review
stage. Criteria and triggers varied in frequency from
common to never detected (Tables 3 and 4). Positive
predictive value (PPV) of criteria and triggers was de-
fined as the number of times a specific criterion/trigger
identified an AE divided by the total number of times
the criterion/trigger was found. Individual criteria and
triggers varied in their yield of detections of AEs and the
percentage (range) of PPV was 40.3% (0.0-80.0) for the
HMPS method and 30.4% (0.0-100.0) for the GTT
(Tables 3 and 4).
Harm
Most AEs, irrespective of the method used, resulted in
minor, transient harm and the majority were judged to
be preventable (Table 5). The main difference between
the methods regarding severity and types of AEs was
found among the ones causing minimal or moderate
impairment (Table 2). These were predominantly urinary
retention, infiltrated intravenous infusions, pressure ulcers
and healthcare-associated infections.
Discussion
The aim of the present study was to evaluate the feasi-
bility and capability of the HMPS method and the GTT
in being able to identify AEs in a specified clinical set-
ting. To the best of our knowledge, this is the first study
that explicitly evaluates these common retrospective
record review methods in the same sample and with the
same definitions. In total 160 AEs were found in 105
(30.0%) of 350 records. The HMPS method confirmed
13% more AEs after the third review stage. The main
difference was found among AEs causing minor or
moderate impairment.
A first interpretation might be that the differences in the
AE rate after review stage 2 depended on the restriction of
review time to 20 minutes in the GTT method. However,
Table 2 Description, nature and known potential underlying causes for the missed AEs after review stage 2
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Table 2 Description, nature and known potential underlying causes for the missed AEs after review stage 2 (Continued)
Rash due to drug E X
Bleeding during surgery X
Increased liver enzymes X






Urinary retention E X




AE, adverse events; HMPS, “Harvard Medical Practice Study”; GTT,” Global Trigger Tool”; NA, Not Applicable for this method.
a 1, minimal impairment, recovery within 1 month.
b 1, the index admission was an unplanned admission related to previous healthcare management within 30 days; 3, hospital-incurred patient injury.
c E, contributed to or resulted in temporary harm to the patient and required intervention; F, contributed to or resulted in temporary harm to the patient and
required initial or prolonged hospitalisation; G, Contributed to or caused permanent patient harm.
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of this restriction. Furthermore, the nurse review time
using the HMPS method was less than for the GTT.
Searching for triggers in different parts of the record may
take longer time than just comprehensively reading the text
and searching for broad criteria in orthopaedic care com-
prising short hospital stays and limited documentation.Table 3 Outcome of the respective criterion in relation to the
Criteria
Hospital-incurred patient injury
Any other undesirable outcome not covered above
Unplanned re-admission after discharge from index admission within 30 day
Healthcare-associated infection or sepsis
Adverse drug reaction
The index admission was an unplanned admission related to previous health
management within 30 days
Dissatisfaction with care documented in the patient’s medical record
Other patient complication
Unplanned return to the operating room
Unplanned removal, injury or repair of an organ during surgery
Unplanned transfer from general care to intensive care
Development of neurological deficit not present on admission
Inappropriate discharge to home
Documentation or correspondence indicating litigation
Cardiac or respiratory arrest
Unplanned transfer to another acute care hospital
Unexpected death
Injury related to abortion or delivery
Total
AE, adverse events; PPV, positive predictive value; NA, not applicable.
All criteria except 1, 2 and 4 must occur during index orthopaedic admission to be
* Including outpatient visits.Record review has been criticised as being too time con-
suming and therefore too expensive [26]. Our results show
that the review times for experienced RNs and physicians
are short and were shorter than, or similar to, those in
other studies [15,27-30]. The length of hospital stays, for
example, most probably affects the review times, making
comparisons between studies difficult. If retrospectiveadverse event
n (%) of positive
criteria




132 (28.3) 83 62.9
87 (18.7) 8 9.2
s* 85 (18.2) 25 29.4
38 (8.2) 22 57.9
33 (7.1) 12 36.4
care 26 (5.6) 13 50.0
16 (3.4) 2 12.5
13 (2.8) 7 53.8
10 (2.1) 2 20.0
5 (1.1) 4 80.0
5 (1.1) 4 80.0
5 (1.1) 3 60.0
5 (1.1) 1 20.0
3 (0.6) 1 33.3
2 (0.4) 1 50.0
1 (0.2) 0 0.0
0 (0.0) 0 0.0
NA
466 (100) 188 40.3
included as positive criteria.
Table 4 Outcome of the respective trigger in relation to the adverse event
Triggers n (%) of positive triggers n of triggers related to AE PPV AE
Procedure 117 (15.9) 25 21.4
Care: other 106 (14.4) 30 28.3
Anti-emetic administration 74 (10.0) 1 1.4
Abrupt drop in haemoglobin 66 (9.0) 2 3.0
Occurrence of any postoperative complication 64 (8.7) 49 76.6
Healthcare-associated infections 60 (8.1) 34 56.7
Re-admission within 30 days 59 (8.0) 13 22.0
Pressure ulcers 33 (4.5) 25 75.8
Return to surgery 21 (2.8) 8 38.1
Falls 16 (2.2) 3 18.8
Transfusion of blood or use of blood products 15 (2.0) 1 6.7
Abrupt medication stop 14 (1.9) 2 14.3
Change of anaesthetic during surgery 13 (1.8) 1 7.7
Removal/injury or repair of organ during operative procedure 10 (1.4) 3 30.0
Vitamin K administration 9 (1.2) 0 0.0
Change in procedure 8 (1.1) 5 62.5
X-ray or Doppler studies for emboli or deep vein thrombosis 7 (0.9) 6 85.7
Codes or arrest 7 (0.9) 3 42.9
Transfer to higher level of care 6 (0.8) 4 66.7
Re-admission to the Emergency Department (ED) within 48 hours 6 (0.8) 1 16.7
Diphenhydramine administration 4 (0.5) 1 25.0
Over-sedation/hypotension 3 (0.4) 2 66.7
Insertion of arterial or central venous line during surgery 3 (0.4) 0 0.0
Post-operative increase in troponin levels 2 (0.3) 2 100.0
Intubation/reintubation / BiPaP in post anaesthesia care unit 2 (0.3) 0 0.0
Consult requested in post anaesthesia care unit 2 (0.3) 0 0.0
Time in ED greater than 6 hours 2 (0.3) 0 0.0
Naloxone administration 2 (0.3) 1 50.0
Clostridium difficile positive stool 1 (0.1) 1 100.0
Admission to intensive care post-operatively 1 (0.1) 1 100.0
Positive blood culture 1 (0.1) 0 0.0
International Normalised Ratio (INR) greater than 6 1 (0.1) 0 0.0
Glucose less than 3 mmol/litre 1 (0.1) 0 0.0
Rising BUN or serum creatinine two times (2x) over baseline 1 (0.1) 0 0.0
Total 737 (100) 224 30.4
AE, adverse events; PPV, positive predictive value.
None of the triggers in the Intensive Care Module (pneumonia onset, readmission to intensive care unit, in-unit procedure or intubation/re-intubation) were
identified in this study.
None of the following triggers were identified in this study; In hospital stroke, dialysis, X-ray intra-operative or in post anaesthesia care unit, intra- or postoperative
death, mechanical ventilation greater than 24 h post-operatively, intra-operative administration of Epinephrine, Norepinephrine, Naloxone or Flumazenil,
pathology reports normal or identifying specimen unrelated to initial surgical diagnosis, operative time greater than 6 h, partial thromboplastin time greater than
100 seconds, and Flumazenil administration.
The five GTT perinatal triggers were not applicable in this study.
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Table 5 Severity and preventability of adverse events
Category of harm HMPS method HMPS method after review
stage 2








n (%) of preventable
AEs
Minimal impairment, recovery within 1 month 116 (76.8) 104 (89.7) 120 (77.4) 108 (90.0)
Moderate impairment, recovery within 1 to 6 months 20 (13.2) 17 (85.0) 20 (12.9) 17 (85.0)
Moderate impairment, recovery within 6 to 12 months 9 (6.0) 6 (66.7) 9 (5.8) 6 (66.7)
Permanent impairment, degree of disability <50% 4 (2.6) 3 (75.0) 4 (2.6) 3 (75.0)
Permanent impairment, degree of disability >50% 1 (0.7) 1 (100.0) 1 (0.6) 1 (100.0)
Contributed to patient death 1 (0.7) 0 (0.0) 1 (0.6) 0 (0.0)
Unable to determine 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Total n of AE 151 (100.0) 131 (86.8) 155 (100.0) 135 (87.1)
Category of harm GTT GTT after review stage 2 GTT after review stage 3
n (%) of
AEs




n (%) of preventable
AEs
E Contributed to or resulted in temporary harm to the patient and
required intervention
51 (51.5) 41 (80.4) 78 (56.9) 63 (80.8)
F Contributed to or resulted in temporary harm to the patient and
required initial or prolonged hospitalisation
42 (42.4) 31 (73.8) 51 (37.2) 40 (78.4)
G Contributed to or caused permanent patient harm 5 (5.1) 5 (100.0) 7 (5.1) 7 (100.0)
H Intervention required to sustain life 1 (1.0) 0 (0.0) 1 (0.7) 0 (0.0)
I Contributed to patient death 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Total n of AE 99 (100.0) 77 (77.8) 137 (100.0) 110 (80.3)
AE, adverse events; HMPS, “Harvard Medical Practice Study”; GTT, “Global Trigger Tool”.
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dent reporting methods, the time used for review may be
cost-effective [8].
Another explanatory factor for differences in the AE
rates may be the perception of AEs. The distinction be-
tween a no-harm incident and a less severe AE is not sharp
and is subject to the individual assessments, which may
affect the outcome of a review process, irrespective of
method used, study design or consensus. Even if studies
are well-planned, definitions and scales may not be fully
clear. A manual cannot describe all conceivable AEs be-
cause situational and individual factors must be applied in
the implicit review. Experience of the specific record sys-
tem and local context, may have affected the numbers of
identified potential AEs in review stage 1. The discrepancy
in AEs between review stages 2 and 3 could be due to dif-
ferences in the two review methods. This study also in-
cluded less severe AEs e.g. infiltrated intravenous infusions.
According to the GTT method, at least as interpreted by
our expert reviewers before the start of the study, these
were not considered as being AEs as they often did not re-
quire any intervention. The difference in AE rate after re-
view stage 3 showed that the physicians in the GTT team
were more likely to reject minor events as AEs than those
in the HMPS method team. Classen et al. [8] have foundthat the greatest variability between the reviewers in sever-
ity categorising of AEs was related to the lowest harm level
in the severity scale used in GTT, category E. The
perception of minor AEs affects the review outcome but
also subsequently the organisation’s input regarding learn-
ing about good safety practice. Olsen [15] stated that even
if an AE caused only minor physical harm, it may still be
detrimental to the patient’s psychological recovery, partici-
pation and trust. Another reason to treat minor AEs as im-
portant is because an AE that causes only minor harm in
one instance might be a sentinel of serious system defects
that could result in major harm in the next case. Patient
safety interventions are needed to reduce major as well as
minor AEs.
We chose to have a common AE definition since the
scope of the study was to evaluate the two methods. The
AE definition used in the present study was broad and did
not require, in contrast to the original HMPS method, that
the patient should have experienced any disability or
prolonged hospital stay as a result of the AE. Several
HMPS method studies have only included the most severe
AE per record. The original GTT method includes all AEs
that cause physical harm and this approach was also used
in our study (Table 1). Consequently, the AE definition
used by the original GTT method may be more sensitive
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ever, the severity scale used in the GTT [7] required an
intervention to be present to qualify as a minor AE (cat-
egory E). The perception of an intervention could have af-
fected both the AE rate and the inter-rater reliability
outcome within the GTT team. Apart from the AE defin-
ition, the severity scale used in the HMPS method is, by
contrast, more inclusive of minor AEs [2,6]. One of the les-
sons learned from the study is that the methods can be
used with different AE definitions than those used origin-
ally in the descriptions of the respective method [1,7].
Individual criteria and triggers varied in their yield of
identified AEs. In this study, some were always associ-
ated with AEs, while others were never associated. Some
of the criteria and triggers were irrelevant for ortho-
paedic care and some were not identified in our sample.
In a study [10] with a larger sample, some triggers were
seldom or never observed, which is in agreement with
our experience. However, the non-specific criterion “any
other undesirable outcome not covered above” and the
triggers “procedure” and “care: other” were commonly
used and may indicate the necessity for providing more
descriptions with examples in the manual in order to
create a more valid and reliable review process. The
PPV is also affected by the larger number of triggers
compared to the number of criteria. Criteria are indefin-
ite about the type of AE that affected the patients
outside index admissions. This has affected the total
PPV positively.
The preventability rates were considerably higher in
this study than those reported in other surgical studies
[31-33] and are more comparable to the preventability
outcome in the Swedish national AE study [6]. This may
be due to the use of experienced reviewers and to the
condition that all reviewers were used to working with
patient safety issues leading to a patient safety perspec-
tive in the review process. Another reason could be that
many nursing related AEs were identified in the present
study, for example pressure ulcers and urinary retention,
and those are often judged as being preventable.
Irrespective of method applied, it is important in clinical
patient safety work to have stable internal review teams
with context knowledge that can lead them to develop
greater expertise and who also produce consistent reviews,
if trends are to be detected in less review time [11]. Sharek
et al. [11] found that an experienced review team identified
substantially more AEs than newly trained internal and ex-
ternal teams did. To use retrospective record review at a
department level and to develop the review process by, for
example, categorising the nature of the AEs according to
the HMPS methodology may be important steps in in-
creasing local safety learning and involvement. The median
review time for the physicians using the HMPS method
was the same as the physicians in the GTT team leading tothe conclusion that categorising the nature of AEs does
not take additional review time. This knowledge can be
used to guide local limited improvement resources into
specific areas and/or processes where tailored interventions
and redesign are necessary to create resilience [13,34].
Limitations
Our study has several limitations besides those traditionally
associated with retrospective record review, for example,
the AE occurrence, severity and preventability can be
overestimated due to hindsight bias; but it can also be
underestimated, due to, for example, incomplete documen-
tation. Context knowledge including knowledge about the
computerised record system may have affected parts of the
outcome. We had one team per method. A cross over
methodology could have reduced possible bias in this as-
pect. Furthermore, a study including more teams, teams
with other skills or records from other medical specialities
may have given different results. This study was limited to
hospital orthopaedic AEs as the aim was to evaluate the
methods at a local level. This affects the ability to general-
ise our findings to other areas of healthcare like elderly
medical care with voluminous notes and most probably
longer review times.
Conclusions and future implications
Retrospective record review is a valuable tool in the identi-
fication of patient safety deficiencies. More AEs were iden-
tified by using the HMPS method than the GTT when
compared to the total number of identified AEs. Hospital
or orthopaedic context knowledge, methodology including
restriction of review time and perception of minor AEs
may have affected the results among expert reviewers. If
this perception of minor AEs is related to the individuals
within the teams or to the methodology itself is unclear.
More studies are needed to further assess different sources
of safety information in healthcare as well as the evaluation
of the capability of different methods to provide decision-
makers and staff with an accurate knowledge of system
weaknesses and underlying patient safety problems.
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